XML 150 R52.htm IDEA: XBRL DOCUMENT v3.25.4
Research and development costs (Tables)
12 Months Ended
Dec. 31, 2025
Research And Development Costs [Abstract]  
Schedule of Research and Development Costs 1 Pre-commercial R&D costs includes $14,103,000 (2024 $2,779,000) of Zircaix inventory that is included within research and development costs, refer to note 15 for further details.
2025
2024
2023
US$'000
US$'000
US$'000
Therapeutics
(Recast)
(Recast)
1.
Phase 3
49,209
36,378
17,585
Phase 2
19,332
8,376
7,937
Early stage clinical candidates
16,995
4,914
4,553
Pre-clinical research and innovation
12,503
6,209
1,183
Total Therapeutics R&D
98,039
55,877
31,258
Precision Medicine
Commercial
18,806
7,139
3,883
Pre-commercial1
46,403
61,831
45,117
Pre-clinical research and innovation
5,947
2,658
4,669
Total Precision Medicine R&D
71,156
71,628
53,669
Total product development R&D
169,195
127,505
84,927
Manufacturing Solutions
Other research and development projects
5,813
425
388
Total Manufacturing Solutions R&D
5,813
425
388
Inter-segment R&D
(3,759)
-
-
Total research and development costs
171,249
127,930
85,315